Gordon B. Mills, MD, PhD, Oral History Interview, September 1, 2016
Files
Download Full Interview Transcript (497 KB)
Loading...
Description
Major Topics Covered:
- Research areas: immunology, targeted therapy, interleukin-2, Women’s Cancer Moon Shot
- Institutional development: Department of Systems Biology, Kleberg Institute, Zayed Institute
- Leadership and contributions in a collaborative context
Interview Chapters
Chapter 08: Department Names Reflect Shifts in an Institution and in Cancer
Chapter 11: The Cancer Genome Atlas and the Positive Side of Serving as Department Chair
Chapter 12: The Kleberg Center for Molecular Markers
Chapter 13: The Zayed Institute for Personalized Cancer Therapy, Part I
Chapter 14: On Leadership, Leading, and Dealing with Kids
Chapter 15: The Zayed Institute for Personalized Cancer Therapy, Part II
Identifier
MillsG_02_20160901
Publication Date
9-1-2016
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Mills, Gordon B. MD, PhD and Rosolowski, Tacey A. PhD, "Gordon B. Mills, MD, PhD, Oral History Interview, September 1, 2016" (2016). Interview Sessions. 13.
https://openworks.mdanderson.org/mchv_interviewsessions/13
Conditions Governing Access
Open
About the Interview
Gordon B. Mills, MD, PhD (b. 3 August 1953, Edmonton, Canada) was recruited to MD Anderson in 1994 to Chair the Department of Molecular Oncology and serve as Chief of the Section of Molecular Therapeutics. In 2006 he founded the first systems biology department focused on cancer in the US. He has served as Chair of the Department of Systems Biology [in the Division of Science] since that time. He has served as co-director of the Zayed Institute for Personalized Cancer Therapy, since 2010 and co-head of the Women's Cancer Moon Shot since 2013. Dr. Mills’ research focuses on the PI3K pathway, lysophospholipids, the genomics and genetics of women’s cancers, and identifying and characterizing a number of potential oncogenes and tumor suppressor genes.